NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Cost-Benefit Analysis Remove constraint Subjects: Cost-Benefit Analysis Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later Publication Year 2000 to 2024 Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

Search Results

21. Mepolizumab (Nucala??, GlaxoSmithKline plc.) for the treatment of severe asthma with eosinophilia: effectiveness, value, and value-based price benchmarks : final report

22. Insulin degludec (Tresiba??, Novo Nordisk A/S) for the treatment of diabetes: effectiveness, value, and value-based price benchmarks : final report

23. Controversies in migraine management: a technology assessment : final report

27. Controversies in obesity management: a technology assessment : final report